Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 22, Issue 10

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 22, Issue 10 (2013)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 22, Issue 10 (2013)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Volume 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Pharmacologic treatment of opioid-induced constipation

Chong-Zhi Wang PhD & Chun-Su Yuan MD PhD

Pages: 1225-1227

Published online: 09 Jul 2013

AbstractforPharmacologic treatment of opioid-induced constipation | Full Text | References | PDF (216 KB)

1427 Views
5 CrossRef citations
0Altmetric

Free Access

Reviews

Review Article

Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

Emma Louise Ashby & Patrick G Kehoe

Pages: 1229-1242

Published online: 26 Jun 2013

AbstractforCurrent status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease | Full Text | References | PDF (601.3 KB)

558 Views
44 CrossRef citations
0Altmetric

Review Article

Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies

Claudio Gasperini, Shalom Haggiag & Serena Ruggieri

Pages: 1243-1253

Published online: 16 Jul 2013

AbstractforDrugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies | Full Text | References | PDF (347.8 KB)

589 Views
10 CrossRef citations
0Altmetric

Review Article

Therapies currently in Phase II trials for malignant pleural mesothelioma

Giulia Pinton, Arcangela Gabriella Manente, Daniela Tavian, Laura Moro & Luciano Mutti

Pages: 1255-1263

Published online: 02 Jul 2013

AbstractforTherapies currently in Phase II trials for malignant pleural mesothelioma | Full Text | References | PDF (407.8 KB)

223 Views
15 CrossRef citations
0Altmetric

Review Article

Targeting tyrosine-kinases in ovarian cancer

Matteo Morotti MD, Christian M Becker MD, Mario Valenzano Menada MD & Simone Ferrero MD PhD

Pages: 1265-1279

Published online: 02 Jul 2013

AbstractforTargeting tyrosine-kinases in ovarian cancer | Full Text | References | PDF (528.2 KB)

361 Views
19 CrossRef citations
0Altmetric

Review Article

Investigational anticoagulants for hematological conditions: a new generation of therapies

Gentian Denas & Vittorio Pengo MD

Pages: 1281-1294

Published online: 22 Jul 2013

AbstractforInvestigational anticoagulants for hematological conditions: a new generation of therapies | Full Text | References | PDF (453.3 KB)

313 Views
6 CrossRef citations
0Altmetric

Review Article

Curcumin: a novel therapeutic for burn pain and wound healing

Bopaiah Cheppudira PhD, Marcie Fowler PhD, Laura McGhee PhD, Angie Greer BS, Alberto Mares MS, Lawrence Petz PhD, David Devore PhD, Dayna R Loyd PhD & John L Clifford PhD

Pages: 1295-1303

Published online: 01 Aug 2013

AbstractforCurcumin: a novel therapeutic for burn pain and wound healing | Full Text | References | PDF (430.4 KB)

747 Views
55 CrossRef citations
0Altmetric

Review Article

Discontinued drugs in 2012: endocrine and metabolic

Jerry R Colca PhD

Pages: 1305-1313

Published online: 21 Aug 2013

AbstractforDiscontinued drugs in 2012: endocrine and metabolic | Full Text | References | PDF (264.5 KB)

391 Views
4 CrossRef citations
0Altmetric

Drug Evaluations

Perifosine – a new option in treatment of acute myeloid leukemia?

Janusz Krawczyk MSc MRCPI FRCPpath, Niamh Keane MB BCh BAO MRCPI, Ronan Swords MD PhD FRCPI FRCPath, Michael O'Dwyer MD FRCPI FRCPath, Ciara L Freeman MB BCh BAO MRCPI & Francis J Giles MB MD FRCPI FRCPath

Pages: 1315-1327

Published online: 09 Aug 2013

Abstractfor Perifosine – a new option in treatment of acute myeloid leukemia? | Full Text | References | PDF (621.5 KB)

177 Views
9 CrossRef citations
0Altmetric

IMA901: a peptide vaccine in renal cell carcinoma

Jens Bedke & Arnulf Stenzl

Pages: 1329-1336

Published online: 31 Jul 2013

Abstractfor IMA901: a peptide vaccine in renal cell carcinoma | Full Text | References | PDF (439 KB)

460 Views
11 CrossRef citations
0Altmetric

NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection

D Alan Herbst BA & K Rajender Reddy MD

Pages: 1337-1346

Published online: 09 Aug 2013

AbstractforNS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infection | Full Text | References | PDF (335.7 KB)

687 Views
30 CrossRef citations
0Altmetric

Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis

Margitta Worm, Deepan Patel & Peter Socrates Creticos

Pages: 1347-1357

Published online: 21 Aug 2013

AbstractforCat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis | Full Text | References | PDF (504 KB)

3062 Views
26 CrossRef citations
0Altmetric

Free Access

Research Article

Article

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Interleukin antagonists for atopic dermatitis: a new era of therapy

Aikaterini Tsiogka et al.

Review Article | Published online: 18 Jun 2024

Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development

Luca Iorio et al.

Report | Published online: 16 Jun 2024

Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, Current treatments and investigational drugs

Lorenza Magagnoli et al.

Review Article | Published online: 16 Jun 2024

VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol

Amanda J. Hooper et al.

Editorial | Published online: 15 Jun 2024

Free Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.22, Iss.10, 2013)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?